Antonella Marchionna, NP
Family · Brandon, MSNPI 1790180107
Payments from drug & device makers
Across 112 payments — averaging $47.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$941
- Novo Nordisk$870
- AstraZeneca$619
- Teva Pharmaceuticals USA, Inc.$417
- Avanir Pharmaceuticals, Inc.$331
- Axsome Therapeutics, Inc.$224
- plus $2K from 27 others
What the payments were for
- Food & beverage$5,271100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 43 | $941 |
| Novo Nordisk | 11 | $870 |
| AstraZeneca(2 entities) | 6 | $619 |
| Teva Pharmaceuticals USA, Inc. | 4 | $417 |
| Avanir Pharmaceuticals, Inc. | 3 | $331 |
| Axsome Therapeutics, Inc. | 2 | $224 |
| Inari Medical, Inc. | 2 | $193 |
| Astellas Pharma Global Development | 1 | $130 |
| Lundbeck LLC | 1 | $125 |
| UCB, Inc. | 1 | $122 |
| Biohaven Pharmaceuticals, Inc. | 8 | $120 |
| Edwards Lifesciences | 1 | $116 |
| Jazz Pharmaceuticals Inc. | 1 | $111 |
| Spinal Simplicity, LLC | 1 | $103 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $103 |
| SK Life Science, Inc. | 1 | $99 |
| Si-bone, Inc. | 1 | $95 |
| Medtronic | 1 | $93 |
| Kyowa Kirin, Inc. | 1 | $87 |
| Merck | 5 | $73 |
| Bioxcel Therapeutics, Inc. | 1 | $57 |
| Johnson & Johnson | 2 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $38 |
| Pfizer | 2 | $27 |
| Lilly USA, LLC | 2 | $26 |
| Amarin Pharma, Inc. | 1 | $17 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
| Paratek Pharmaceuticals, Inc. | 1 | $14 |
| Astellas Pharma US Inc | 1 | $13 |
| Daiichi Sankyo Inc. | 1 | $13 |
| Xeris Pharmaceuticals, Inc. | 1 | $13 |
| Boehringer Ingelheim | 1 | $12 |
| Nabriva Therapeutics, PLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NUEDEXTA$244
- Wegovy$229
- Veozah$130
- VYEPTI$125
- Auvelity$125
- VRAYLAR$123
- Briviact$122
- AJOVY$119
- RYBELSUS$119
- FLOWTRIEVER CATHETER, S$111
- CT THROMBECTOMY SYSTEM KIT$111
- SUNOSI$111
- HA MINUTEMAN G3-R$103
- RELISTOR$103
- LOKELMA$100
How this compares
$5,271 in reported general payments places this provider in the 90th percentile of 3,007 family providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other family in Brandon
- Karen FreemanBrandon$22K
- Cinda PerrymanFayette$888K
- Dodie McGeeRaymond$772K
- Gina BurgeJackson$237K
- Christy DavisJackson$208K
- Maranda EversollFlowood$197K
- Dana DelaskiJackson$158K
- Kristin CarrollJackson$158K
- Shannon FryeryOxford$127K
- Nativel CollinsMantachie$73K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.